Skip to main content

Table 3 Survival analyses associated with clinicodemographic or pathological patient characteristics

From: TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer

Characteristics n 5-Year DFS(%) p 5 Year DSS(%) p
Age ≤ 50 31 55.8 0.999 58.2 0.895
Age > 50 30 54.6   61.4  
cT (Clinical = Physical exam&Radiological)    0.624   0.526
 T1–2 30 55.7   62.9  
 T3–4 31 53.9   57.2  
cN    0.719   0.441
 N0–1 39 55.6   64.0  
 N2–3 22 52.3   52.1  
ypN*    0.031*   0.008*
 ypN0 23 73.9   78.0  
 ypN1–3 38 43.6   48.1  
Pathological findings after NAC    0.367   0.230
Invasive ductal carcinoma 40 48.0   54.6  
Other 21 66.0   69.7  
*MDACC Residual Cancer Burden Index    0.049*   0.041*
Class 0 (=pathologic complete response) 9 88.9   88.9  
Class I-II-III 51 49.3   53.0  
*MDACC Residual Cancer Burden Index    0.038*   0.037*
Class 0–1 (=pathologic complete response) 13 83.9   83.9  
Class II-III 47 48.1   52.7  
  1. NAC Neoadjuvant chemotherapy, *p < 0.05